Last deal

$20M

Amount

Post-IPO Equity

Stage

28.06.2024

Date

13

all rounds

$218.4M

Total amount

General

About Company
Allurion Technologies develops a non-surgical, swallowable gastric balloon for weight loss.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Elipse, SGL Medical, Allurion Technologies Holdings, Inc.

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's innovative device is a thin, flexible polymer film that is delivered in a capsule, eliminating the need for surgery, endoscopy, and anesthesia. The Allurion Programme combines medical, digital, and nutritional approaches to help obese patients reduce their food intake and develop lifelong healthy habits. Since its founding in 2009, Allurion has already helped thousands of people worldwide to lose weight and transform their lives.
Contacts